Literature DB >> 16081223

Colorectal cancer among Asians and Pacific Islanders in the U.S.: survival disadvantage for the foreign-born.

John H Choe1, Thomas D Koepsell, Patrick J Heagerty, Vicky M Taylor.   

Abstract

BACKGROUND: Asian Americans and Pacific Islanders (AAPI) have better colorectal cancer survival than other racial populations. However, immigrants face challenges that may place them at higher risk for late diagnosis and death.
METHODS: To compare survival between the foreign- and U.S.-born, we identified 17,302 AAPI colorectal cancer patients between 1973 and 1998 from the Surveillance, Epidemiology, and End-Results (SEER) Program. Patients were categorized as foreign-born or U.S.-born using multiple imputation methods.
RESULTS: Foreign birth was associated with higher risk for death from any cause (hazard ratio [HR] 1.29; 95% CI 1.23-1.36) and with modestly higher risk after adjustment for selected demographic characteristics (HR 1.13; 95% CI 1.05-1.21) and registry site (HR 1.05; 95% CI 0.98-1.14). Although foreign-born AAPI were more likely to present later, additional adjustment for cancer stage reduced but did not eliminate their higher risk of death (HR 1.09; 95% CI 1.01-1.18)
CONCLUSIONS: Compared to the U.S.-born, foreign-born AAPI have poorer survival following colorectal cancer diagnosis. Future investigation of the care processes after diagnosis may be important in understanding these differences.

Entities:  

Mesh:

Year:  2005        PMID: 16081223     DOI: 10.1016/j.cdp.2005.06.002

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  8 in total

1.  Quality of cancer care among foreign-born and US-born patients with lung or colorectal cancer.

Authors:  Signe Smith Nielsen; Yulei He; John Z Ayanian; Scarlett Lin Gomez; Katherine L Kahn; Dee W West; Nancy L Keating
Journal:  Cancer       Date:  2010-07-29       Impact factor: 6.860

2.  Hidden breast cancer disparities in Asian women: disaggregating incidence rates by ethnicity and migrant status.

Authors:  Scarlett Lin Gomez; Thu Quach; Pamela L Horn-Ross; Jane T Pham; Myles Cockburn; Ellen T Chang; Theresa H M Keegan; Sally L Glaser; Christina A Clarke
Journal:  Am J Public Health       Date:  2010-02-10       Impact factor: 9.308

3.  Uncovering nativity disparities in cancer patterns: Multiple imputation strategy to handle missing nativity data in the Surveillance, Epidemiology, and End Results data file.

Authors:  Jane R Montealegre; Renke Zhou; E Susan Amirian; Michael E Scheurer
Journal:  Cancer       Date:  2014-01-16       Impact factor: 6.860

4.  Treatment and outcomes of gastric cancer among United States-born and foreign-born Asians and Pacific Islanders.

Authors:  Stacey A Dacosta Byfield; Craig C Earle; John Z Ayanian; Ellen P McCarthy
Journal:  Cancer       Date:  2009-10-01       Impact factor: 6.860

5.  Prevalence of colorectal neoplasms in Asian Americans.

Authors:  Khoa D Lam; Ruel T Garcia; Long H Nguyen; Huy Trinh; George Triadafilopoulos; Jeanine T Phan; Khanh Nguyen; Huy Nguyen; Aijaz Ahmed; Mindie H Nguyen
Journal:  Dig Dis Sci       Date:  2008-10-31       Impact factor: 3.199

6.  Does ethnicity affect survival following colorectal cancer? A prospective, cohort study using Iranian cancer registry.

Authors:  Ali Ahmadi; Seyed Saeed Hashemi Nazari; Mahmoud Mobasheri
Journal:  Med J Islam Repub Iran       Date:  2014-07-27

7.  Longitudinal, population-based study of racial/ethnic differences in colorectal cancer survival: impact of neighborhood socioeconomic status, treatment and comorbidity.

Authors:  Scarlett Lin Gomez; Cynthia D O'Malley; Antoinette Stroup; Sarah J Shema; William A Satariano
Journal:  BMC Cancer       Date:  2007-10-16       Impact factor: 4.430

8.  Cancer survival discrepancies in developed and developing countries: comparisons between the Philippines and the United States.

Authors:  M T Redaniel; A Laudico; M R Mirasol-Lumague; A Gondos; D Pulte; C Mapua; H Brenner
Journal:  Br J Cancer       Date:  2009-02-24       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.